The Moroccan LRRK2 Registry: Building Resources to Investigate the Penetrance and Phenotype of LRRK2 in North Africans
Objective: The Moroccan LRRK2 Registry aims to establish a comprehensive database integrating clinical data and biosamples to provide valuable insights into the penetrance, phenotype, and…Superior cluneal neuralgia in Parkinson’s disease: frequency and clinical features.
Objective: We investigated the frequency and clinical characteristics of superior cluneal neuralgia (SCN) in patients with Parkinson's disease (PD). Background: The superior cluneal nerve is…Semi-quantitative Evaluation of Midbrain Accumulation in 123I-FP-CIT SPECT in Parkinson’s disease and Parkinsonian Syndromes
Objective: To establish a method for evaluating midbrain accumulation of 123I-FP-CIT SPECT and assess its ability to differentiate between Parkinson’s disease (PD) and Parkinsonian syndromes…Myofascial pain syndromes in parkinsonism
Objective: To study of pain syndromes in parkinsonism Background: Myofascial Pain Syndrome (MPS) is a common but underdiagnosed pain disorder in Parkinson’s disease (PD), marked…Quantifying Bradykinesia in Real-world Practice: A Clinician-friendly Video Analysis Tool for Parkinson’s Disease
Objective: To develop and validate a video-based automated analysis tool for the objective and quantitive assessment of bradykinesia in Parkinson’s disease (PD). Background: Currently, evaluating…HPRT1 Gene Mutation in a Young Male with Early Childhood Onset Seizures-Parkinsonism and Levodopa-Induced Dyskinesia: A Case Report
Objective: To report the clinical course, diagnostic evaluation, and genetic findings in a 24-year-old male with early childhood onset tremor, seizures ,bradykinesia and rigidity ,…Carbidopa/levodopa related hypotension in patients with alpha-synucleinopathies
Objective: Evaluate blood pressure response to levodopa/carbidopa in patients with synucleinopathies undergone to autonomic testing. Background: Carbidopa/levodopa is the mainstay treatment of patients with synucleinopathies,…Rethinking Parkinsonism: Limitations in Clinical Diagnosis
Objective: To highlight the limitations in clinically differentiating PD and MSA. Background: The antemortem differentiation of parkinsonian syndromes remains challenging due to overlapping symptomatology, particularly…Unveiling a rare case: Novel TBK1 variant presenting as Multiple system atrophy-like phenotype
Objective: Tumour necrosis factor NF-ƘB activator (TANK) binding kinase 1 (TBK1) is necessary for immune and inflammatory responses. Reports of TBK1 with neurodegeneration are noted…Beyond the Classic Triad: An Unusual Phenomenology of Parkinsonism in a Patient with Superficial Siderosis (SS)
Objective: To highlight the phenomenology in a complex case of superficial siderosis (SS) presenting with hearing loss, ataxia, and parkinsonism Background: SS is a rare…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 405
- Next Page »